ZINORMEDICAL

  • English
  • French
  • German

ZINORMEDICAL IS A BRANCH OF BIOMEDIX SA SWITZERLAND

Zinormedical is developing
new, innovative patented medical devices to treat
Gastro(o)esophageal Reflux Disease (GERD/GORD) and OBESITY
through the mouth without surgery.

Dr.Norman

DM-GARD

The Diagnostic-Management GARD(TM) device, abbreviated as DM-GARD, can be used in patients who have atypical symptoms that do not include the classical symptoms: acid heartburn or regurgitation. The most common
atypical symptoms are voice changes, chronic cough, chest pain.

More

TH-GARD

The Therapeutic GARD, abbreviated as Th-GARD, can be used for treatment of moderate-to-severe sufferers of GERD who are having increasingly longer bouts of reflux and do not respond to Proton Pump Inhibitors (PPIs) or cannot stop PPIs after several months or years of treatment.

More

OB-GARD

The OB-GARD is an anti-obesity device, within the GARD FAMILY of devices. It incorporates new technology in the esophagus and extend further into the stomach. The restriction created by this tubular device will restrict the rate at which patients can eat, and reduce the overall volume that can be consumed...

More

About the founder and CEO

The founder and CEO of the company is Dr. Norman Godin, who has been practicing gastroenterology in private practice in Geneva for over 25 years and has had over 10,000 patients of whom more than 3000 have had GERD.

Dr. Godin was formerly a Fellow in Gastroenterology at Mount Sinai Hospital in New York City and Chief Resident in Gastroenterology at Geneva University Hospital where he studied medicine.

About Us

ZinorMedical is a branch of Biomedix SA Switzerland. Biomedix SA, the mother company of ZinorMedical focuses on developing new medical devices to treat Gastro-Esophageal Reflux Disease (GERD) heartburn as well as OBESITY through the mouth with a flexible endoscope.

For further information contact us at:

Call us: Call us: +41 22 738 16 46

Fax us: Fax us: +41 22 738 20 71